{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T06:22:20Z","timestamp":1769840540009,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.xphs.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T01:58:30Z","timestamp":1658455110000},"page":"166-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preparation and Characterization of Clopidogrel Bisulfate-hydroxypropyl-\u03b2-Cyclodextrin Mixed Inclusion Complex for Improved Intestinal Solubility and Anti-Thrombotic Efficacy"],"prefix":"10.1016","volume":"112","author":[{"given":"Akashdeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurav","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.xphs.2022.07.005_bib0001","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.xphs.2021.07.008","article-title":"Formulation development, in vitro and in vivo evaluation of topical hydrogel formulation of econazole nitrate-loaded \u03b2-cyclodextrin nanosponges","volume":"110","author":"Srivastava","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.07.005_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115287","article-title":"Cyclodextrin solubilization and complexation of antiretroviral drug lopinavir: In silico prediction; Effects of derivatization, molar ratio and preparation method","volume":"227","author":"Adeoye","year":"2020","journal-title":"Carbohydr Polym"},{"issue":"2","key":"10.1016\/j.xphs.2022.07.005_bib0003","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijpharm.2017.04.050","article-title":"Cyclodextrin nanosystems in oral drug delivery: a mini review","volume":"531","author":"Adeoye","year":"2017","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2022.07.005_bib0004","first-page":"1274","article-title":"Cyclodextrins as excipients in tablet formulations","volume":"23","author":"Concei\u00e7\u00e3o","year":"2018","journal-title":"Drug Discov"},{"issue":"1-2","key":"10.1016\/j.xphs.2022.07.005_bib0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijpharm.2016.09.036","article-title":"Comparison in toxicity and solubilizing capacity of hydroxypropyl-\u03b2-cyclodextrin with different degree of substitution","volume":"513","author":"Li","year":"2016","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2022.07.005_bib0006","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fct.2005.03.007","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin (HP-\u03b2-CD): a toxicology review","volume":"43","author":"Gould","year":"2005","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"10.1016\/j.xphs.2022.07.005_bib0007","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2022.07.005_bib0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/13880209.2015.1021816","article-title":"Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation","volume":"54","author":"Zhao","year":"2016","journal-title":"Pharm Biol"},{"issue":"3","key":"10.1016\/j.xphs.2022.07.005_bib0009","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1081\/PDT-100100556","article-title":"Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-\u03b2-cyclodextrin","volume":"5","author":"Miyake","year":"2000","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.xphs.2022.07.005_bib0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.carbpol.2014.11.017","article-title":"Inclusion complexes of chloramphenicol with \u03b2-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production","volume":"121","author":"Aiassa","year":"2015","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2022.07.005_bib0011","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.carbpol.2018.10.038","article-title":"Synthesis and characterization of supramolecular systems containing nifedipine, \u03b2-cyclodextrin and aspartic acid","volume":"205","author":"Cerutti","year":"2019","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2022.07.005_bib0012","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.carbpol.2013.12.047","article-title":"Valsartan inclusion by methyl-\u03b2-cyclodextrin: thermodynamics, molecular modelling, Tween 80 effect and evaluation","volume":"103","author":"Chadha","year":"2014","journal-title":"Carbohydr Polym"},{"issue":"1","key":"10.1016\/j.xphs.2022.07.005_bib0013","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpba.2005.11.029","article-title":"Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization","volume":"42","author":"Cirri","year":"2006","journal-title":"J Pharm Biomed Anal"},{"issue":"2s","key":"10.1016\/j.xphs.2022.07.005_bib0014","doi-asserted-by":"crossref","first-page":"s16","DOI":"10.5530\/jyp.2020.12s.41","article-title":"Design and characterization of bilayered floating tablets of clopidogrel bisulfate and aspirin using natural gums","volume":"12","author":"Devarapalli","year":"2020","journal-title":"J Young Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2022.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1067\/mva.2002.122027","article-title":"Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action","volume":"35","author":"Payne","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.xphs.2022.07.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.06.008","article-title":"Stabilizing excipients for engineered clopidogrel bisulfate procubosome derived in situ cubosomes for enhanced intestinal dissolution: Stability and bioavailability considerations","volume":"136","author":"El-Laithy","year":"2019","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2022.07.005_bib0017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40005-018-0405-5","article-title":"Quality by design based development and optimization of novel gastroretentive floating osmotic capsules of clopidogrel bisulfate","volume":"49","author":"Shah","year":"2019","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.xphs.2022.07.005_bib0018","first-page":"c18","article-title":"Cubosomes as oral drug delivery systems: a promising approach for enhancing the release of clopidogrel bisulphate in the intestine","author":"El-Laithy","year":"2018","journal-title":"Chem Pharm Bull"},{"issue":"8","key":"10.1016\/j.xphs.2022.07.005_bib0019","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1208\/s12249-017-0805-2","article-title":"Development of novel high density gastroretentive multiparticulate pulsatile tablet of clopidogrel bisulfate using quality by design approach","volume":"18","author":"Desai","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2022.07.005_bib0020","series-title":"Formulations Containing Clopidogrel and Sulfoalkyl Ether Cyclodextrin and Methods of Use","author":"Mosher","year":"2019"},{"issue":"1","key":"10.1016\/j.xphs.2022.07.005_bib0021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/2230-973X.127736","article-title":"Design, development and evaluation of clopidogrel bisulfate floating tablets","volume":"4","author":"Rao","year":"2014","journal-title":"Int J Pharm Investig"},{"issue":"06","key":"10.1016\/j.xphs.2022.07.005_bib0022","first-page":"297","article-title":"Bioequivalence study of two different clopidogrel bisulfate film-coated tablets","volume":"59","author":"Richter","year":"2009","journal-title":"Arzneimittelforschung"},{"issue":"7","key":"10.1016\/j.xphs.2022.07.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181199","article-title":"Gallic acid\/hydroxypropyl-\u03b2-cyclodextrin complex: Improving solubility for application on in vitro\/in vivo Candida albicans biofilms","volume":"12","author":"Teodoro","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.xphs.2022.07.005_bib0024","first-page":"1","article-title":"Development of novel high density gastroretentive multiparticulate pulsatile tablet of clopidogrel bisulfate using quality by design approach","author":"Desai","year":"2017","journal-title":"AAPS Pharmscitech"},{"issue":"02","key":"10.1016\/j.xphs.2022.07.005_bib0025","article-title":"Bilayer tablets: atorvastatin calcium nanoparticles and clopidogrel bisulfate sustained release formulation","volume":"11","author":"Subramanian","year":"2017","journal-title":"Asian J Pharm"},{"key":"10.1016\/j.xphs.2022.07.005_bib0026","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.carbpol.2015.08.012","article-title":"Inclusion complex of erlotinib with sulfobutyl ether-\u03b2-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation","volume":"134","author":"Devasari","year":"2015","journal-title":"Carbohydr Polym"},{"issue":"12","key":"10.1016\/j.xphs.2022.07.005_bib0027","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/js9801889","article-title":"Combined effect of complexation and pH on solubilization","volume":"87","author":"Li","year":"1998","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2022.07.005_bib0028","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0731-7085(03)00529-6","article-title":"Study of freeze-dried quercetin\u2013cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis","volume":"34","author":"Pralhad","year":"2004","journal-title":"J Pharm Biomed Anal"},{"issue":"3","key":"10.1016\/j.xphs.2022.07.005_bib0029","first-page":"171","article-title":"Characterization of cyclodextrin inclusion complexes\u2014a review","volume":"2","author":"Singh","year":"2010","journal-title":"J Pharm Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2022.07.005_bib0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejpb.2003.10.020","article-title":"Solubility enhancement of celecoxib using \u03b2-cyclodextrin inclusion complexes","volume":"57","author":"Rawat","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2022.07.005_bib0031","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10973-011-1406-z","article-title":"Complexation of nevirapine with \u03b2-cyclodextrins in the presence and absence of Tween 80: characterization, thermodynamic parameters, and permeability flux","volume":"105","author":"Chadha","year":"2011","journal-title":"J Therm Anal Calorim"},{"issue":"2","key":"10.1016\/j.xphs.2022.07.005_bib0032","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/02652048.2018.1453560","article-title":"Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells","volume":"35","author":"Patel","year":"2018","journal-title":"J Microencapsul"},{"key":"10.1016\/j.xphs.2022.07.005_bib0033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.carbpol.2016.08.089","article-title":"QbD based synthesis and characterization of polyacrylamide grafted corn fibre gum","volume":"156","author":"Singh","year":"2017","journal-title":"Carbohydr Polym"},{"issue":"4","key":"10.1016\/j.xphs.2022.07.005_bib0034","first-page":"240","article-title":"GC\/MS, FTIR and NMR studies for the identification and characterization of clopidogrel bisulfate degradation products","volume":"49","author":"Housheh","year":"2015","journal-title":"Indian J Pharm Educ Res"},{"key":"10.1016\/j.xphs.2022.07.005_bib0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.carbpol.2015.07.073","article-title":"Physicochemical and functional performance of pectin extracted by QbD approach from Tamarindus indica L. pulp","volume":"134","author":"Sharma","year":"2015","journal-title":"Carbohydr Polym"},{"issue":"3","key":"10.1016\/j.xphs.2022.07.005_bib0036","first-page":"151","article-title":"Modified starch as gel base of chlorhexidine gluconate for periodontitis treatment","volume":"20","author":"Yodkhum","year":"2010","journal-title":"J Met Mater Miner"},{"key":"10.1016\/j.xphs.2022.07.005_bib0037","first-page":"1","article-title":"In-process and finished products quality control tests for pharmaceutical capsules according to pharmacopoeias","author":"Uddin","year":"2016","journal-title":"J pharm res"},{"key":"10.1016\/j.xphs.2022.07.005_bib0038","first-page":"117","article-title":"A phase solubility technique","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv Anal Chem Instrum"},{"issue":"3","key":"10.1016\/j.xphs.2022.07.005_bib0039","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00280-009-1060-3","article-title":"Inclusion complexes of noscapine in \u03b2-cyclodextrin offer better solubility and improved pharmacokinetics","volume":"65","author":"Madan","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2022.07.005_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejps.2005.01.021","article-title":"Characterization of the 13-cis-retinoic acid\/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis","volume":"25","author":"Yap","year":"2005","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2022.07.005_bib0041","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/17425247.2.1.335","article-title":"Cyclodextrins in drug delivery","volume":"2","author":"Loftsson","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2022.07.005_bib0042","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10847-011-0034-3","article-title":"Binary and ternary inclusion complexes of dapsone in cyclodextrins and polymers: preparation, characterization and evaluation","volume":"73","author":"Grebogi","year":"2012","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"7","key":"10.1016\/j.xphs.2022.07.005_bib0043","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.bmc.2009.02.044","article-title":"Binary and ternary inclusion complexes of finasteride in HP\u03b2CD and polymers: Preparation and characterization","volume":"17","author":"Asbahr","year":"2009","journal-title":"Bioorg Med Chem"},{"issue":"1-2","key":"10.1016\/j.xphs.2022.07.005_bib0044","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2005.05.042","article-title":"Evaluation of cyclodextrin solubilization of drugs","volume":"302","author":"Loftsson","year":"2005","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.xphs.2022.07.005_bib0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/js950534b","article-title":"Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization","volume":"85","author":"Loftsson","year":"1996","journal-title":"J Pharm Sci"},{"issue":"1-4","key":"10.1016\/j.xphs.2022.07.005_bib0046","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10847-006-9247-2","article-title":"The complexation efficiency","volume":"57","author":"Loftsson","year":"2007","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"9","key":"10.1016\/j.xphs.2022.07.005_bib0047","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/js990097r","article-title":"Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants","volume":"88","author":"Li","year":"1999","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2022.07.005_bib0048","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpba.2004.06.013","article-title":"Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin","volume":"36","author":"Tommasini","year":"2004","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2022.07.005_bib0049","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.carbpol.2016.04.022","article-title":"Inclusion complexes of HP-\u03b2-cyclodextrin with agomelatine: Preparation, characterization, mechanism study and in vivo evaluation","volume":"147","author":"Liao","year":"2016","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.xphs.2022.07.005_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/193049","article-title":"Comparison of three molecular simulation approaches for cyclodextrin-ibuprofen complexation","author":"Wang","year":"2015","journal-title":"J Nanomater"},{"issue":"3","key":"10.1016\/j.xphs.2022.07.005_bib0051","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1208\/s12249-014-0257-x","article-title":"Effects of the preparation method on the formation of true nimodipine SBE-\u03b2-CD\/HP-\u03b2-CD inclusion complexes and their dissolution rates enhancement","volume":"16","author":"Semcheddine","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"1-2","key":"10.1016\/j.xphs.2022.07.005_bib0052","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijpharm.2018.10.047","article-title":"D-optimal mixture design: Formulation development, mechanical characterization, and optimization of curcumin chewing gums using oppanol\u00ae B 12 elastomer as a gum-base","volume":"553","author":"Al Hagbani","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2022.07.005_bib0053","series-title":"Clopidogrel Bisulfate. Profiles of Drug Substances, Excipients and Related Methodology","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1871-5125(10)35002-3","author":"Lestari","year":"2010"},{"issue":"3","key":"10.1016\/j.xphs.2022.07.005_bib0054","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10847-009-9554-5","article-title":"Inclusion complex of usnic acid with \u03b2-cyclodextrin: characterization and nanoencapsulation into liposomes","volume":"64","author":"Lira","year":"2009","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"7","key":"10.1016\/j.xphs.2022.07.005_bib0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3109\/10717544.2013.853213","article-title":"Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-\u03b2-cyclodextrin","volume":"21","author":"Nair","year":"2014","journal-title":"Drug Deliv"},{"issue":"1-2","key":"10.1016\/j.xphs.2022.07.005_bib0056","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5173(02)00078-9","article-title":"Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-\u03b2-cyclodextrin","volume":"239","author":"Charoenchaitrakool","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2022.07.005_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2020.109723","article-title":"Inclusion complexation of catechins-rich green tea extract by \u03b2-cyclodextrin: Preparation, physicochemical, thermal, and antioxidant properties","volume":"131","author":"Reddy","year":"2020","journal-title":"LWT"},{"issue":"1-3","key":"10.1016\/j.xphs.2022.07.005_bib0058","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.molstruc.2010.06.014","article-title":"Studies on a novel modified \u03b2-cyclodextrin inclusion complex","volume":"979","author":"Ding","year":"2010","journal-title":"J Mol Struct"},{"issue":"1","key":"10.1016\/j.xphs.2022.07.005_bib0059","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0928-0987(01)00208-1","article-title":"Physicochemical characterization and in vitro dissolution behavior of nicardipine\u2013cyclodextrins inclusion compounds","volume":"15","author":"Fernandes","year":"2002","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2022.07.005_bib0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40262-014-0230-6","article-title":"Clinical pharmacokinetics and pharmacodynamics of clopidogrel","volume":"54","author":"Jiang","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2022.07.005_bib0061","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jchromb.2005.05.013","article-title":"Estimation of carboxylic acid metabolite of clopidogrel in Wistar rat plasma by HPLC and its application to a pharmacokinetic study","volume":"821","author":"Singh","year":"2005","journal-title":"J Chromatogr B"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922002969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922002969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:37:13Z","timestamp":1758361033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922002969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0022354922002969"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.07.005","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and Characterization of Clopidogrel Bisulfate-hydroxypropyl-\u03b2-Cyclodextrin Mixed Inclusion Complex for Improved Intestinal Solubility and Anti-Thrombotic Efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}